Episode #25
The Price of Pain: How the Opioid Epidemic Was Engineered
The episode argues that the opioid crisis was not a failed risk calculation but a knowingly scaled, dangerous product driven by “profit first” incentives, echoing a broader cultural shift. It focuses on Purdue Pharma and the Sackler family, who had internal data undermining claims that OxyContin was less addictive yet aggressively marketed it, influenced guidelines, and shaped regulators. We explore how authority bias, framing, social proof, and status quo effects were leveraged through pain societies, “pain as the fifth vital sign,” influential physicians, and normalized side-effect disclaimers to manipulate perceived risk. We discuss conflicts of interest and regulatory capture at the FDA, plus distributors ignoring data red flags despite duties to monitor suspicious orders. Concluding, we call for risk programs that account for financial motivation but extend beyond profit to long-term human well-being.
